Mast cells as therapeutic target in cancer

Eur J Pharmacol. 2016 May 5:778:152-7. doi: 10.1016/j.ejphar.2015.02.056. Epub 2015 Apr 24.

Abstract

Mast cells promote tumorigenesis and tumor progression, and have functions that favor the host. Increased mast cell number correlates with a poor prognosis in several human tumors. In different vascular tumors, as well as a number of hematological and solid tumors, mast cell accumulation correlate with increased neovascularization, tumor aggressiveness, and metastatic spread. Mast cells might act as a new target for the adjuvant treatment of tumors through the selective inhibition of angiogenesis, tissue remodeling and tumor-promoting molecules, permitting the secretion of cytotoxic cytokines and preventing mast cell-mediated immune suppression.

Keywords: Anticancer agents; Mast cells; Tryptase; Tumor growth; Tyrosine kinase inhibitors.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cell Proliferation / drug effects
  • Humans
  • Mast Cells / drug effects*
  • Molecular Targeted Therapy / methods*
  • Neoplasms / blood supply
  • Neoplasms / drug therapy*
  • Neoplasms / immunology*
  • Neoplasms / pathology
  • Neovascularization, Pathologic